Jones Lang LaSalle | 02/06/2014
Four new corporate real estate strategies can help life sciences companies thrive in the new normal
Facing the full impact of healthcare reform initiatives in the United States and elsewhere, life sciences companies are tackling a dramatic new reality. The transition to value-based medicine is intensifying attention to research productivity, while regulatory pressures are growing, requiring specialized facilities management expertise just as seasoned talent begins to retire. As life sciences...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma 2026 | AI Commercial, Medical & Patient Care
September 9 - 10, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More
Pharmaceutical Launch Excellence Summit US
September 30 - October 1 2026
Hyatt Regency Boston Harbor, Boston, US
Register Now |
View Agenda |
Learn More